DCAL

Dishman Carbogen Amcis Share PriceDishman Carbogen Amcis

₹132.55
3.9 (3.03%)
As on 22 March, 2023 | 01:53 BSE: 540701 NSE: DCAL

Dishman Carbogen Amcis Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Dishman Carbogen Amcis

Start SIP

Dishman Carbogen Amcis Share Price

  • Over 1 Month 8.56%
  • Over 3 Month 46.95%
  • Over 6 Month 29.38%
  • Over 1 Year -26.14%

Dishman Carbogen Amcis Key Statistics

P/E Ratio -561.7
PEG Ratio -5.9
Market Cap Cr 2,078
Price to Book Ratio 0.4
EPS -2
Dividend 0
Relative Strength Index 68.8
Money Flow Index 73.52
MACD Signal 8.41
Average True Range 7.38

Dishman Carbogen Amcis Investment Rating

  • Master Rating:
  • Dishman Carbogen Amcis has an operating revenue of Rs. 2,363.35 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 25% and 20% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 30 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Dishman Carbogen Amcis Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 7810710483
Operating Expenses Qtr Cr 8210510182
Operating Profit Qtr Cr -3131
Depreciation Qtr Cr 3353534
Interest Qtr Cr 15141310
Tax Qtr Cr -4-10-15-38
Net Profit Qtr Cr -7-17-255

Dishman Carbogen Amcis Technicals

EMA & SMA

Current Price
₹132.55
3.9 (3.03%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 122.24
  • 50 Day
  • 110.53
  • 100 Day
  • 106.68
  • 200 Day
  • 114.89
  • 20 Day
  • 123.78
  • 50 Day
  • 103.36
  • 100 Day
  • 100.78
  • 200 Day
  • 107.27

Dishman Carbogen Amcis Resistance and Support

PIVOT
₹129.72
Resistance
First Resistance 133.44
Second Resistance 138.22
Third Resistance 141.94
RSI 68.8
MFI 73.52
MACD Single Line 8.41
MACD 8.17
Support
First Resistance 124.94
Second Resistance 121.22
Third Resistance 116.44

Dishman Carbogen Amcis Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,260,644 34,188,665 27.12
Week 760,976 28,711,609 37.73
1 Month 1,816,270 59,700,792 32.87
6 Month 859,425 35,777,848 41.63

Dishman Carbogen Amcis Result Highlights

Dishman Carbogen Amcis Synopsis

NSE-Medical-Diversified

Dishman Carbogen Amc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 302.79 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2022. Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338.
Market Cap 2,078
Sales 372
Shares in Float 6.43
No of funds 53
Yield
Book Value 0.49
U/D Vol ratio 2.2
LTDebt / Equity 3
Alpha -0.11
Beta 1.11

Dishman Carbogen Amcis

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 59.32%59.32%59.32%
Mutual Funds 3.63%4.26%6.54%
Foreign Portfolio Investors 7.2%6.2%5.85%
Individual Investors 25.65%25.85%23.72%
Others 4.2%4.37%4.57%

Dishman Carbogen Amcis Management

Name Designation
Mr. Janmejay R Vyas Chairman
Mr. Arpit J Vyas Global Managing Director
Mrs. Deohooti J Vyas Whole Time Director
Mr. Sanjay S Majmudar Independent Director
Mr. Ashok C Gandhi Independent Director
Mr. Rajendra S Shah Independent Director
Mr. Subir Kumar Das Independent Director
Mr. Maitri K Mehta Director

Dishman Carbogen Amcis Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Dishman Carbogen Amcis MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Pure Value Fund Growth 3798
HSBC Flexi Cap Fund - Growth 3350
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 2538
Motilal Oswal S&P BSE Healthcare ETF 6

Dishman Carbogen Amcis FAQs

What is Share Price of Dishman Carbogen Amcis ?

Dishman Carbogen Amcis share price is ₹132 As on 22 March, 2023 | 01:39

What is the Market Cap of Dishman Carbogen Amcis ?

The Market Cap of Dishman Carbogen Amcis is ₹2078.2 Cr As on 22 March, 2023 | 01:39

What is the P/E ratio of Dishman Carbogen Amcis ?

The P/E ratio of Dishman Carbogen Amcis is -561.7 As on 22 March, 2023 | 01:39

What is the PB ratio of Dishman Carbogen Amcis ?

The PB ratio of Dishman Carbogen Amcis is 0.4 As on 22 March, 2023 | 01:39

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number